Intended for UK patients prescribed Soprobec
where you can find information about your medicine and how to use it.
Please read the Soprobec Patient Information Leaflet (PIL)
carefully. A paper copy is provided with your medicine and an
online version can be found here. If you have any questions,
please ask your doctor, nurse or pharmacist.
The following information is provided to supplement the PIL; it does not replace the important information you can find there.
Doctors follow treatment guidelines based on the latest clinical
evidence, to ensure every patient is on the most suitable
treatment for them.1
The two main types of asthma medication are known as
preventers and relievers. Soprobec is a preventer and is
prescribed by doctors to help prevent symptoms such as
wheezing and breathlessness, by reducing inflammation
of the airways in the lungs.
If you have any questions about your asthma medication,
talk to your doctor, nurse or pharmacist.
They reduce inflammation in your lungs
They help ease breathing problems
They contribute to long-term asthma management
They get medicine to the lungs straight away if you have an asthma attack
The medicine opens up the airways in the lungs to help ease your breathing
The medicine starts working within minutes of using the inhaler
Using your inhaler should be simple, but it is important to know how to use it properly and this website will help you with this.
If you have previously been prescribed and used Clenil®, there is no need for you to adjust your inhaler technique.
Your doctor, nurse or pharmacist can also help and will check regularly that you are using your inhaler correctly. If you are
unsure about anything or have any problems inhaling, do not hesitate to ask them for advice. You will also find instructions
on using your inhaler in the Patient Information Leaflet that comes with every pack.
To remove the mouthpiece cover, hold between the thumb and forefinger, squeeze gently and pull apart as shown. Check inside and outside to make sure that the mouthpiece is clean, and that there are no foreign objects.
Testing your inhaler: If the inhaler is new or if it has not been used for three days or more, one puff should be released into the air to make sure that it works.
Hold the inhaler upright as shown, with your thumb on the base, below the mouthpiece. Breathe out as far as is comfortable.
Place the mouthpiece in your mouth between your teeth and close your lips around it but do not bite it.
Just after starting to breathe in through your mouth press down on the top of the inhaler to release a puff while still breathing in steadily and deeply.
Hold your breath; take the inhaler from your mouth and your finger from the top of the inhaler. Continue holding your breath for a few seconds or as long as is comfortable. Breathe out slowly.
If you are to take another puff, keep the inhaler upright and wait about half a minute before repeating steps 2 to 5.
After use, always replace the mouthpiece cover to keep out dust and fluff. Replace firmly and snap into position.
Important: Do not rush steps 2, 3, 4 and 5.
A device called a VolumaticTM spacer should always be used when:
It is important that you start to breathe in as slowly as possible just before operating the inhaler. Practise in front of a mirror for the first few times.
If you see ‘mist’ coming from the top of the inhaler or the sides of your mouth, the medication will not get into your lungs as it should. Take another puff, carefully following the instructions from step 2 onwards.
People with weak hands, or children, may find it easier to hold the inhaler with both hands. Put the two forefingers on top of the inhaler and both thumbs on the bottom below the mouthpiece.
If you find it difficult to operate the inhaler while starting to breathe in you may want to use a spacer device. Ask your doctor, pharmacist or nurse about this device.
Important – please read the Patient Information Leaflet that comes with your medicine. You can also download it here.
What is Soprobec and what is a preventer?
Soprobec belongs to a group of asthma treatments known as 'preventers', which are used every day to help prevent asthma symptoms from occuring. The active ingredient of Soprobec, beclometasone dipropionate, reduces the inflammation and irritation in the walls of the small air passages in the lungs, helping to ease breathing problems.2 It is important to take it every day, even if you have no symptoms.3
How can I be sure I've got the right colour inhaler?
Soprobec inhalers come in different colours on the inhalers and caps, depending on the dose (strength) you need. Your inhaler might be cream, grey, red or pink. Your pharmacist will dispense the correct colour inhaler for you, as prescribed by your doctor.
How do I use Soprobec?
Always use your inhaler exactly as your doctor, nurse or pharmacist has told you, and check with them if you are not sure. Step by step instructions on using your inhaler can be found here and in the Patient Information Leaflet. It is very important to use your Soprobec inhaler regularly and not to stop treatment even if you feel better, unless your doctor, nurse or pharmacist tells you to do so.
Why is it important to have a good inhaler technique?
Your Soprobec prescription has been carefully calculated by your doctor or nurse to suit your needs. It is important to make sure you inhale the correct number of puffs at the right times. Good inhaler technique is essential for successful therapy.
How should Soprobec be stored?
As with all medicines, keep Soprobec out of the sight and reach of children. The canister contains a pressurised liquid. Protect from frost, heat and direct sunlight, do not expose to high temperatures (above 50°C) and do not puncture or burn (incinerate), even when empty.
How do I clean my Soprobec device?
You should clean your inhaler at least once a week.
Asthma is a long-term condition that can be challenging to live with,but there is plenty of support available for children and adults.
View latest Government advice here
Soprobec® is a registered trademark of Glenmark Pharmaceuticals Europe Limited. Clenil® Modulite® are registered trademarks of Chiesi Limited. VolumaticTM is a trademark of the GlaxoSmithKline group of companies
© 2023 Glenmark Pharmaceuticals Europe Ltd. All rights reserved. Date of preparation: April 2023 NP-UK-SOP-0042 V6
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
